Jacobi Capital Management LLC Navidea Biopharmaceuticals, Inc. Transaction History

Jacobi Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.0 - $1.82 $1,000 - $1,820	-1,000 Closed	0 $0
Q2 2020 Aug 04, 2020	SELL	$0.7 - $4.16 $1,363 - $8,103	-1,948 Reduced 66.08%	1,000 $4,000
Q2 2020 Jul 27, 2020	BUY	$0.7 - $4.16 $1,363 - $8,103	1,948 Added 194.8%	2,948 $4,000
Q2 2019 Aug 07, 2019	BUY	$0.62 - $3.6 $620 - $3,600	1,000 New	1,000 $1,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.